Keyword: Foamix

Xenotransplantation firm eGenesis hires new R&D head; Relay adds execs to chemistry, R&D; and Navidea brings on new CMO focused on imaging.

Foamix's topical antibiotic for rosacea achieved “treatment success” in about half of the 1,522 patients enrolled in two phase 3 trials.